Cigna Investments Inc. New Sells 24 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cigna Investments Inc. New decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,634 shares of the medical equipment provider’s stock after selling 24 shares during the quarter. Cigna Investments Inc. New’s holdings in Intuitive Surgical were worth $1,897,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Sovran Advisors LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $250,000. Stonebridge Financial Group LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth $343,000. Focus Financial Network Inc. grew its holdings in shares of Intuitive Surgical by 17.1% in the fourth quarter. Focus Financial Network Inc. now owns 1,491 shares of the medical equipment provider’s stock valued at $778,000 after purchasing an additional 218 shares during the period. Summit Trail Advisors LLC grew its holdings in shares of Intuitive Surgical by 21.1% in the fourth quarter. Summit Trail Advisors LLC now owns 6,602 shares of the medical equipment provider’s stock valued at $3,446,000 after purchasing an additional 1,150 shares during the period. Finally, Sycomore Asset Management lifted its position in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after buying an additional 4,079 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the stock. Truist Financial raised their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Leerink Partners raised their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. CICC Research initiated coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. Royal Bank of Canada lifted their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,940 shares of company stock valued at $3,346,964. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $595.70 on Tuesday. The company’s fifty day simple moving average is $554.85 and its two-hundred day simple moving average is $514.80. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market capitalization of $212.18 billion, a price-to-earnings ratio of 92.93, a PEG ratio of 5.67 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.